Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Provectus Pharma (PVCT)

Provectus Pharma (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Provectus Pharma 800 S Gay Street Suite 1610 KNOXVILLE TN 37929 USA

www.provectusbio.com P: 866-594-5999

Description:

Provectus Biopharmaceuticals specializes in developing oncology and dermatology therapies. The company's product portfolio consists of PV-10 Melanoma, PH-10 Psoriasis, PH-10 Atopic Dermatitis, PV-10 Breast Cancer, PV-10 Liver Metastasis and PV-10 Mechanism of Action which are in clinical trials. Provectus Biopharmaceuticals Inc., formerly known as Provectus Pharmaceuticals, Inc., is based in Knoxville, Tennessee.

Key Statistics

Overview:

Market Capitalization, $K 81,005
Enterprise Value, $K 79,995
Shares Outstanding, K 419,497
Annual Sales, $ 560 K
Annual Net Income, $ -3,100 K
Last Quarter Sales, $ 120 K
Last Quarter Net Income, $ -660 K
EBIT, $ -2,890 K
EBITDA, $ -2,880 K
60-Month Beta 0.69
% of Insider Shareholders 12.00%
% of Institutional Shareholders 0.05%
Float, K 369,157
% Float 88.00%
Short Volume Ratio 0.37

Growth:

1-Year Return 56.23%
3-Year Return 185.23%
5-Year Return 329.11%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 50.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.00 on 03/28/24
Latest Earnings Date 05/09/24 [--]
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

PVCT Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % -189.49%
Profit Margin % -553.57%
Debt/Equity 0.00
Price/Sales 143.82
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.02
Interest Coverage -13.09
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar